0001209191-17-062901.txt : 20171129 0001209191-17-062901.hdr.sgml : 20171129 20171129173906 ACCESSION NUMBER: 0001209191-17-062901 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171128 FILED AS OF DATE: 20171129 DATE AS OF CHANGE: 20171129 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Naughton Gail K CENTRAL INDEX KEY: 0001297506 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34375 FILM NUMBER: 171229443 MAIL ADDRESS: STREET 1: C. R. BARD, INC. STREET 2: 730 CENTRAL AVENUE CITY: MURRAY HILL STATE: NJ ZIP: 07974 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CYTORI THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001095981 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 330827593 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3020 CALLAN ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8584580900 MAIL ADDRESS: STREET 1: 3020 CALLAN ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121 FORMER COMPANY: FORMER CONFORMED NAME: MACROPORE INC DATE OF NAME CHANGE: 20010320 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-11-28 0 0001095981 CYTORI THERAPEUTICS, INC. CTYX 0001297506 Naughton Gail K 3020 CALLAN ROAD SAN DIEGO CA 92121 1 0 0 0 Subscription Rights (Right to Buy) 1000.00 2017-11-28 4 X 0 1 D 2017-11-02 2017-11-21 see footnote 0 D Series B Preferred Stock 0.3333 2017-11-28 4 X 0 1 A 2017-11-28 Common Stock 3000 1 D Warrants (Right to Buy) 0.3333 2017-11-28 4 X 0 1800 A 2020-05-28 Common Stock 1800 1800 D The preferred stock and the warrants reported on this Form 4 were acquired pursuant to the exercise of subscription rights previously distributed by Cytori Therapeutics, In. (the "Company") to all holders of the Company's common stock on October 27, 2017. The subscription rights entitled each recipient to purchase units ("Units"). Each Unit consists of one share of the Company's Series B Preferred Stock (convertible into 3,000 shares of the Company's common stock) and 1,800 warrants, with each warrant representing the right to purchase one share of the Company's common stock. The purchase price for each Unit was $1,000. The Series B Preferred Stock has no expiration date. Each warrant entitles the holder to purchase one share of the Company's common stock at an exercise price of $0.3333 per share from the date the Company receives stockholder approval of an amendment to its certificate of incorporation to increase its authorized shares of common stock through May 28, 2020. Tiago Girao, By Power of Attorney For: Gail Naughton 2017-11-29